Pick's Disease

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 156-164

  Munoz, David G ^a   Morris, Huw R ^b   Rossor, Martin ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer type lesions; Cortical atrophy; Pick bodies; Pick's disease, neurodegenerative disorder; PiD pathogenesis; Progressive non fluent aphasia (PNFA); Selective susceptibility; Tau isoform pre mRNA transcripts; Ventricular dilation; Von economo neurons

Indexed keywords

EID: 84873037206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch16     Document Type: Chapter

References (51)

1. Dickson DW. Neuropathology of Pick's disease. Neurology 2001; 56: S16-S20.
2. Constantinidis J, Richard J, Tissot R. Pick's disease. Histological and clinical correlations. Eur Neurol 1974; 11: 208-217.
3. Cairns NJ, Bigio EH, Mackenzie IR et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl) 2007; 114: 5-22.
4. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-1621.
5. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
6. Josephs KA, Holton JL, Rossor MN et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30: 369-373.
7. Forman MS, Farmer J, Johnson JK et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-962.
8. Shi J, Shaw CL, Du PD et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol (Berl) 2005; 110: 501-512.
9. Yokota O, Tsuchiya K, Arai T et al. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions. Acta Neuropathol 2009; 117: 429-444.
10. Hodges JR, Davies RR, Xuereb JH et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
11. Morris HR, Baker M, Yasojima K et al. Analysis of tau haplotypes in Pick's disease. Neurology 2002; 59: 443-445.
12. Bronner IF, Ter Meulen BC, Azmani A et al. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 2005; 128: 2645-2653.
13. Dermaut B, Kumar-Singh S, Engelborghs S et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 2004; 55: 617-626.
14. Halliday GM, Song YJ, Lepar G et al. Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol 2005; 57: 139-143.
15. Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain 2005; 128: 1984-1995.
16. Sparks DL, Danner FW, Davis DG, Hackney C, Landers T, Coyne CM. Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual. J Neuropathol Exp Neurol 1994; 53: 37-42.
17. Green AJ, Harvey RJ, Thompson EJ, Rossor MN. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease. Neurosci Lett 1999; 259: 133-135.
18. Johannesson G, Brun A, Gustafson I, Ingvar DH. EEG in presenile dementia related to cerebral blood flow and autopsy findings. Acta Neurol Scand 1977; 56: 89-103.
19. Dickson DW. Pick's disease: a modern approach. Brain Pathol 1998; 8: 339-354.
20. Hansen LA, DeTeresa R, Tobias H, Alford M, Terry RD. Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol 1988; 131: 507-518.
21. Tsuchiya K, Ikeda M, Hasegawa K et al. Distribution of cerebral cortical lesions in Pick's disease with Pick bodies: a clinicopathological study of six autopsy cases showing unusual clinical presentations. Acta Neuropathol (Berl) 2001; 102: 553-571.
22. Tsuchiya K, Piao YS, Oda T et al. Pathological heterogeneity of the precentral gyrus in Pick's disease: a study of 16 autopsy cases. Acta Neuropathol 2006; 112: 29-42.
23. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol (Berl) 1996; 92: 588-596.
24. Armstrong RA, Cairns NJ, Lantos PL. Clustering of Pick bodies in the dentate gyrus in Pick's disease. Neuropathology 2000; 20: 170-175.
25. Yasuhara O, Kawamata T, Aimi Y, McGeer EG, McGeer PL. Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases. Neurosci Lett 1994; 170: 13-16.
26. Rewcastle NB, Ball MJ. Electron microscopic structure of the "inclusion bodies" in Pick's disease. Neurology 1968; 18: 1205-1213.
27. Munoz-Garcia D, Ludwin SK. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study. Ann Neurol 1984; 16: 467-480.
28. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996; 55: 53-67.
29. Komori T. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 1999; 9: 663-679.
30. Braak E, Arai K, Braak H. Cerebellar involvement in Pick's disease: affliction of mossy fibers, monodendritic brush cells, and dentate projection neurons. Exp Neurol 1999; 159: 153-163.
31. Arai H, Noguchi I, Makino Y, Kosaka K, Heizmann CW, Iizuka R. Parvalbumin-immunoreactive neurons in the cortex in Pick's disease. J Neurol 1991; 238: 200-202.
32. Braak H, Braak E. Involvement of precerebellar nuclei in Pick's disease. Exp Neurol 1998; 153: 351-365.
33. Braak H, Braak E. Pick's disease: cytoskeletal changes in the hypothalamic lateral tuberal nucleus. Brain Res 1998; 802: 119-124.
34. Seeley WW. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr Opin Neurol 2008; 21: 701-707.
35. Craig AD. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 2009; 10: 59-70.
36. Nimchinsky EA, Gilissen E, Allman JM, Perl DP, Erwin JM, Hof PR. A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci USA 1999; 96: 5268-5273.
37. Bell K, Cairns NJ, Lantos PL, Rossor MN. Immunohistochemistry distinguishes: between Pick's disease and corticobasal degeneration. J Neurol Neurosurg Psychiatry 2000; 69: 835-836.
38. Buee-Scherrer V, Hof PR, Buee L et al. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol (Berl) 1996; 91: 351-359.
39. Delacourte A, Sergeant N, Wattez A, Gauvreau D, Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 1998; 43: 193-204.
40. Connell JW, Rodriguez-Martin T, Gibb GM et al. Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res 2005; 137: 104-109.
41. Arai T, Ikeda K, Akiyama H et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 2001; 101: 167-173.
42. Procter AW, Qurne M, Francis PT. Neurochemical features of frontotemporal dementia. Dement Geriatr Cogn Disord 1999; 10 Suppl 1: 80-84.
43. Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998; 8: 355-365.
44. Mackenzie IR, Neumann M, Bigio EH et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119: 1-4.
45. Fujita K, Ito H, Nakano S, Kinoshita Y, Wate R, Kusaka H. Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease. Acta Neuropathol 2008; 116: 439-445.
46. Munoz DG, Neumann M, Kusaka H et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009; 118: 617-627.
47. Ishihara T, Hong M, Zhang B et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999; 24: 751-762.
48. Lee VM, Trojanowski JQ. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease. Neurology 2001; 56: S 26-S 30.
49. Goedert M. Tau gene mutations and their effects. Mov Disord 2005; 20 Suppl 12: S45-S52.
50. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62: 42-52.
51. Vossel KA, Miller BL. New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol 2008; 21: 708-716.